dermatology-995x60
NEWS
- Anacor Pharmaceuticals Announces Positive Results From The Second Phase 3 Trial Of Tavaborole For Onychomycosis
- Sanofi And Regeneron Report Positive Proof-of-Concept Data For Dupilumab
- Portola And Lee's Pharmaceutical Enter Into Agreement To Expand Phase 3 APEX Study Of Betrixaban Into China
- Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, In Patients With Epilepsy
- ViroPharma And Halozyme Provide Update On Clinical Development Of Subcutaneous Cinryze® (C1 Esterase Inhibitor [Human]) With Recombinant Human Hyaluronidase (rHuPH20)
ABOUT
This website uses cookies to ensure you get the best experience on our website. Learn more